Please login to the form below

Not currently logged in
Email:
Password:

blinatumomab

This page shows the latest blinatumomab news and features for those working in and with pharma, biotech and healthcare.

Amgen buys BeiGene stake for $2.7bn to aid push into China

Amgen buys BeiGene stake for $2.7bn to aid push into China

BeiGene will sell  Xgeva (denosumab) for cancer that has spread to the bones, multiple myeloma therapy  Kyprolis(carfilzomib) and  Blincyto (blinatumomab) for leukaemia in China on a profit-sharing basis, according

Latest news

More from news
Approximately 4 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics